Legal Representation
Attorney
Howard I. Sobelman
USPTO Deadlines
Next Deadline
41 days remaining
Final Refusal E-Mailed
Due Date
August 19, 2025
Extension Available
Until November 19, 2025
Application History
15 events| Date | Code | Type | Description |
|---|---|---|---|
| May 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 30, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| May 30, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 19, 2025 | GNFR | O | FINAL REFUSAL E-MAILED |
| May 19, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| May 19, 2025 | CNFR | R | FINAL REFUSAL WRITTEN |
| Mar 25, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 24, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 24, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 8, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 8, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 8, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 20, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 17, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 17, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, injectable pharmaceuticals and diet pills for the treatment of weight loss
First Use Anywhere:
Jul 9, 2024
First Use in Commerce:
Jul 9, 2024
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
GLP